COMPANY

UCB Pharma

HQ: Brussels, Belgium source · ucb.com ↗

Location: Brussels, Belgium · source · Oct 14, 2026

Profile checked Oct 10, 2026

Keywords: Rheumatoid Arthritis Epilepsy Painful Diabetic Neuropathy Partial Epilepsy Systemic Lupus Erythematosus Postherpetic Neuralgia Crohn's Disease Advanced Idiopathic Parkinson's Disease Arthritis Unverricht-Lundborg Disease Non-Squamous Non-Small-Cell Lung Cancer Narcolepsy With Cataplexy Partial-onset Seizures Generalized Epilepsy Seasonal Allergic Rhinitis Psoriasis Chronic Plaque Psoriasis Atopic Dermatitis Tonic-clonic Epilepsy Rhinitis Allergic Seasonal CDP6038 Lacosamide Certolizumab Pegol Brivaracetam SPM927/Lacosamide SPM 929 Seletracetam (UCB44212) CDP791 Sodium Oxybate (Xyrem) Brivaracetam (ucb 34714)

275Trials (company is sponsor)

Timeline

2014-11 Trial start Phase 3: An Open-label Extension Study of Certolizumab Pegol in Chinese Patients With Rheumatoid Arthritis Who Enrolled in RA0044 source ↗
Feb 13, 2014 Trial start Phase 2: A Study to Investigate the Safety and Efficacy of Lacosamide Added to the Patients Current Therapy in Patients Aged 1 Month to Less Than 18 Years Old With Epilepsy Syndromes Associated With G source ↗
Mar 26, 2013 Trial start Phase 3: Study to Evaluate the Safety, Tolerability, and Efficacy of Long-term Adjunctive Therapy With Lacosamide in Adults With Partial-onset Seizures source ↗
2012-12 Trial start —: Noninterventional Examination of Subcutaneous (sc) Tumor Necrosis Factor (TNF) Inhibitors source ↗
2012-09 Trial start Phase 1: A Study to Investigate the Drug-Drug Interactions of Brivaracetam and Ethanol in Healthy Male Subjects source ↗
2012-03 Trial start Phase 4: Sleep Efficiency Assessed by Polysomnography (PSG Sleep Lab Testing) in Advanced Parkinson's Disease source ↗
2012-01 Trial start Phase 3: A Multi-center, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Certolizumab Pegol in Combination With Methotrexate in the Treatment of Disease Modif source ↗
2012-01 Trial start Phase 3: A Multi-center, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Certolizumab Pegol in Combination With Methotrexate in the Treatment of Disease Modif source ↗
Aug 1, 2011 Trial start Phase 3: Open-label Long-term Study of Adjunctive Brivaracetam in Pediatric Subjects With Epilepsy source ↗
2011-07 Trial start Phase 3: Open Label Extension Study of Epratuzumab in Subjects With Systemic Lupus Erythematosus source ↗
2010-12 Trial start Phase 3: Brivaracetam Efficacy and Safety Study in Subjects With Partial Onset Seizures source ↗
2010-12 Trial start Phase 3: Study of Epratuzumab Versus Placebo in Subjects With Moderate to Severe General Systemic Lupus Erythematosus (SLE) source ↗
2010-12 Trial start Phase 3: Study of Epratuzumab Versus Placebo in Subjects With Moderate to Severe General Systemic Lupus Erythematosus source ↗
2010-11 Trial start Phase 2: Efficacy and Safety of CDP6038 in Patients With Rheumatoid Arthritis With an Unsuccessful Response to Anti-Tumor Necrosis Factor (Anti-TNF) Therapy source ↗
2010-08 Trial start Phase 2: Extension Study to Assess Long Term Safety in Children and Adolescents With Crohn's Disease Receiving Certolizumab Pegol source ↗
2009-11 Trial start Phase 2: A Multicenter, Open-Label Study To Investigate The Safety And Pharmacokinetics Of Lacosamide In Children With Partial Seizures source ↗
2009-10 Trial start Phase 1/Phase 2: To Evaluate the Blood Levels and Safety of IV and Subcutaneous CDP6038 in Subjects With Rheumatoid Arthritis Using Methotrexate source ↗
Sep 1, 2009 Trial start —: National Data Bank for Rheumatic Disease Registry Study of Safety in Patients With Rheumatoid Arthritis Treated With Cimzia® or Disease-modifying Antirheumatic Drugs (DMARDs) source ↗
2008-03 Trial start Phase 4: A Study Evaluating the Efficacy and Impact on Health-related Quality of Life of Levocetirizine in Adults With Seasonal Allergic Rhinitis source ↗
2007-09 Trial start Phase 3: Double-blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset Seizures source ↗
2007-09 Trial start Phase 3: Double-blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset Seizures source ↗
2006-11 Trial start Phase 3: Brivaracetam as add-on Treatment of Unverricht-Lundborg Disease (ULD) in Adolescents and Adults source ↗
2006-08 Trial start Phase 3: A Study to Look at the Efficacy and Safety of Keppra® Extended Release Formulation - XR source ↗
Jun 30, 2006 Trial start Phase 3: A Trial to Assess the Efficacy and Safety of 400mg/Day Lacosamide in Subjects With Painful Diabetic Neuropathy source ↗
Apr 10, 2006 Trial start Phase 1: Exploratory Clinical Study to Evaluate Sodium Oxybate (Xyrem) on Potential Endocrine Changes source ↗

Showing 25 of 50 dated events.

Clinical trials (lead sponsor) Showing 50 of 275

Record	Title	Phase	Status	Start	Primary completion
NCT01521923	A Multi-center, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Certolizumab Pegol in Combination With Methotrexate in the Treatment of Disease Modifying Antirheumatic Drugs (DMARD)-naïve Adults With Early Active Rheumatoid Arthritis	Phase 3	Completed	2012-01	2015-07 (actual)
NCT01519791	A Multi-center, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Certolizumab Pegol in Combination With Methotrexate in the Treatment of Disease Modifying Antirheumatic Drugs (DMARD)-naïve Adults With Early Active Rheumatoid Arthritis	Phase 3	Completed	2012-01	2014-07 (actual)
NCT01364597	Open-label Long-term Study of Adjunctive Brivaracetam in Pediatric Subjects With Epilepsy	Phase 3	Completed	Aug 1, 2011	Feb 3, 2022 (actual)
NCT01519882	Sleep Efficiency Assessed by Polysomnography (PSG Sleep Lab Testing) in Advanced Parkinson's Disease	Phase 4	Terminated	2012-03	2012-12 (actual)
NCT01009242	To Evaluate the Blood Levels and Safety of IV and Subcutaneous CDP6038 in Subjects With Rheumatoid Arthritis Using Methotrexate	Phase 1/Phase 2	Completed	2009-10	2010-09 (actual)
NCT01242488	Efficacy and Safety of CDP6038 in Patients With Rheumatoid Arthritis With an Unsuccessful Response to Anti-Tumor Necrosis Factor (Anti-TNF) Therapy	Phase 2	Completed	2010-11	2012-06 (actual)
NCT00861068	A Multi-Centre, Randomized, Double-Blind, Placebo Controlled Pilot Trial to Assess the Efficacy, Safety, and Tolerability of SPM 927 in Subjects With Postherpetic Neuralgia (PHN).	Phase 2	Completed	2002-02	2002-12 (actual)
NCT00800215	A Trial to Investigate the Safety, Tolerability and Pharmacokinetics of Intravenous SPM 927	Phase 2	Completed	Mar 4, 2004	Aug 17, 2004 (actual)
NCT00350103	A Trial to Assess the Efficacy and Safety of 400mg/Day Lacosamide in Subjects With Painful Diabetic Neuropathy	Phase 3	Completed	Jun 30, 2006	Jun 29, 2007 (actual)
NCT00150709	A Study Of The Safety And Efficacy Of Levetiracetam (Keppra®) (Ucb L059) In Children With Epilepsy	Phase 3	Completed	Jan 26, 1998	Jan 25, 2006 (actual)
NCT00861042	An Open-label follow-on Trial to Assess the Long-term Safety and Efficacy of Oral SPM 927 in Subjects With Diabetic Neuropathy	Phase 2	Completed	2002-04	2004-12 (actual)
NCT00546351	Study Evaluating Long-term Safety and Efficacy of Lacosamide in Subjects With Painful Distal Diabetic Neuropathy.	Phase 3	Completed	2004-05	2011-01 (actual)
NCT00152503	Study With Subjects 18-65 Years Old With Partial Onset Seizures Who Are Currently Taking Levetiracetam	Phase 2	Completed	Aug 31, 2005	May 12, 2006 (actual)
NCT00220337	A Trial to Assess the Long-term Safety and Efficacy of Lacosamide in Subjects With Painful Diabetic Neuropathy	Phase 3	Completed	Dec 21, 2004	Oct 31, 2007 (actual)
NCT00368251	Brivaracetam as add-on Treatment of Unverricht-Lundborg Disease (ULD) in Adolescents and Adults	Phase 3	Completed	2006-11	2008-01 (actual)
NCT01261325	Brivaracetam Efficacy and Safety Study in Subjects With Partial Onset Seizures	Phase 3	Completed	2010-12	2014-05 (actual)
NCT00490035	Double-blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset Seizures	Phase 3	Completed	2007-09	2009-02 (actual)
NCT00464269	Double-blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset Seizures	Phase 3	Completed	2007-09	2008-12 (actual)
NCT00152477	A Study of Paclitaxel/Carboplatin With or Without CDP791 in Patients With Lung Cancer	Phase 2	Completed	Aug 15, 2005	Jun 25, 2009 (actual)
NCT00345800	Exploratory Clinical Study to Evaluate Sodium Oxybate (Xyrem) on Potential Endocrine Changes	Phase 1	Completed	Apr 10, 2006	Jan 22, 2008 (actual)
NCT00175916	Follow-up Trial to Evaluate Long-term Safety and Efficacy of Brivaracetam in Subjects Suffering From Epilepsy	Phase 3	Completed	2005-09	2019-05 (actual)
NCT01832038	Study to Evaluate the Safety, Tolerability, and Efficacy of Long-term Adjunctive Therapy With Lacosamide in Adults With Partial-onset Seizures	Phase 3	Completed	Mar 26, 2013	Jul 31, 2019 (actual)
NCT01764321	Noninterventional Examination of Subcutaneous (sc) Tumor Necrosis Factor (TNF) Inhibitors	Not listed	Completed	2012-12	Jun 16, 2020 (actual)
NCT01190410	Extension Study to Assess Long Term Safety in Children and Adolescents With Crohn's Disease Receiving Certolizumab Pegol	Phase 2	Completed	2010-08	Nov 27, 2017 (actual)
NCT01261793	Study of Epratuzumab Versus Placebo in Subjects With Moderate to Severe General Systemic Lupus Erythematosus (SLE)	Phase 3	Completed	2010-12	2015-05 (actual)
NCT00160602	A Study of Liquid Certolizumab Pegol as Additional Medication to Methotrexate in the Treatment of Signs and Symptoms of Rheumatoid Arthritis and in Prevention of Joint Damage in Patients With Active Rheumatoid Arthritis	Phase 3	Completed	2005-06	2006-09 (actual)
NCT00152386	A Placebo Controlled Study to Assess Efficacy and Safety of Certolizumab Pegol in the Treatment of Rheumatoid Arthritis	Phase 3	Completed	2005-02	2006-10 (actual)
NCT00175890	A Placebo-controlled Study of Levetiracetam In Children (1mo to 4yrs of Age) With Partial Onset Seizures.	Phase 3	Completed	2004-10	2007-01 (actual)
NCT00160654	Open Label Safety and Efficacy Study of Levetiracetam in Patients With Epilepsy	Phase 4	Completed	Nov 24, 2003	Dec 12, 2006 (actual)
NCT00291668	Clinical Study of CDP870/Certolizumab Pegol in Patients With Active Crohn's Disease	Phase 2	Completed	Mar 2, 2006	Nov 8, 2007 (actual)
NCT00615615	Efficacy and Tolerability of Levetiracetam Add-On Treatment in Refractory Pediatric Patients With Partial Onset Seizures	Phase 3	Completed	1999-09	2003-03 (actual)
NCT00150748	Long Term Follow up Treatment With Levetiracetam in Subjects of 4 Years and Older With Generalized Epilepsy	Phase 3	Completed	2001-11	2007-07 (actual)
NCT00621959	A Study Evaluating the Efficacy and Impact on Health-related Quality of Life of Levocetirizine in Adults With Seasonal Allergic Rhinitis	Phase 4	Completed	2008-03	2008-06 (actual)
NCT01095393	National Data Bank for Rheumatic Disease Registry Study of Safety in Patients With Rheumatoid Arthritis Treated With Cimzia® or Disease-modifying Antirheumatic Drugs (DMARDs)	Not listed	Completed	Sep 1, 2009	Dec 13, 2016 (actual)
NCT00368069	A Study to Look at the Efficacy and Safety of Keppra® Extended Release Formulation - XR	Phase 3	Completed	2006-08	2007-05 (actual)
NCT00160641	A Study of the Safety and Effectiveness of Liquid Certolizumab Pegol in the Treatment of Signs and Symptoms of Rheumatoid Arthritis and in Prevention of Joint Damage in Patients With Active Rheumatoid Arthritis	Phase 3	Completed	2005-11	2012-02 (actual)
NCT00175877	A Study of the Safety and Effectiveness of Lyophilized Certolizumab Pegol in the Treatment of Signs and Symptoms of Rheumatoid Arthritis and in Prevention of Joint Damage in Patients With Active Rheumatoid Arthritis	Phase 3	Completed	2005-06	2012-02 (actual)
NCT01969851	A Study to Investigate the Safety and Efficacy of Lacosamide Added to the Patients Current Therapy in Patients Aged 1 Month to Less Than 18 Years Old With Epilepsy Syndromes Associated With Generalized Seizures.	Phase 2	Completed	Feb 13, 2014	Apr 10, 2018 (actual)
NCT00329303	Efficacy of Re-treatment With Cimzia® in Subject With Chronic Plaque Psoriasis	Phase 2	Completed	2006-04	2007-05 (actual)
NCT00245765	Efficacy Study of CDP870 in Subjects With Chronic Plaque Psoriasis Who Are Candidate for Systemic Therapy and/or Phototherapy/Photochemotherapy	Phase 2	Completed	2005-10	2006-11 (actual)
NCT00938431	A Multicenter, Open-Label Study To Investigate The Safety And Pharmacokinetics Of Lacosamide In Children With Partial Seizures	Phase 2	Completed	2009-11	2014-08 (actual)
NCT00160667	A Study Assessing Efficacy of Brivaracetam in Subjects With Persistent Pain After Shingles (Post-herpetic Neuralgia)	Phase 2	Completed	Oct 11, 2004	Jan 5, 2006 (actual)
NCT00152464	Prevention of Asthma With Levocetirizine 18 Month Treatment in Infants (12 - 24 Months) Suffering From Eczema (Atopic Dermatitis) and Sensitized to Grass Pollen and/or House Dust Mite (HDM)	Phase 3	Completed	Mar 20, 2002	Mar 15, 2006 (actual)
NCT00150813	Monotherapy With Levetiracetam in Patients Suffering From Epilepsy.	Phase 3	Completed	Aug 10, 2005	May 29, 2007 (actual)
NCT02319642	An Open-label Extension Study of Certolizumab Pegol in Chinese Patients With Rheumatoid Arthritis Who Enrolled in RA0044	Phase 3	Completed	2014-11	2016-12 (actual)
NCT01710670	A Study to Investigate the Drug-Drug Interactions of Brivaracetam and Ethanol in Healthy Male Subjects	Phase 1	Completed	2012-09	2012-11 (actual)
NCT01408576	Open Label Extension Study of Epratuzumab in Subjects With Systemic Lupus Erythematosus	Phase 3	Completed	2011-07	2016-02 (actual)
NCT00175825	A Dose-ranging Study With Brivaracetam in Patients From 16 to 65 Years With Refractory Partial Onset Seizures.	Phase 2	Completed	Nov 7, 2005	Jun 29, 2006 (actual)
NCT01262365	Study of Epratuzumab Versus Placebo in Subjects With Moderate to Severe General Systemic Lupus Erythematosus	Phase 3	Completed	2010-12	2015-05 (actual)
NCT00291642	A Study to Compare the Efficacy of Levocetirizine to Placebo in Reducing Symptoms of Seasonal Allergic Rhinitis (SAR) in Sensitive Subjects Exposed to Ragweed Pollen	Phase 2	Completed	Jan 1, 2006	Apr 1, 2006 (actual)